<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Colorectal cancer TNM staging AJCC UICC 8th edition</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Colorectal cancer TNM staging AJCC UICC 8th edition</h1>
<div class="graphic"><div class="figure"><div class="ttl">Colorectal cancer TNM staging AJCC UICC 8th edition</div><div class="cntnt"><table cellspacing="0"><colgroup span="4" width="25%"></colgroup> <tbody> <tr> <td class="subtitle1_left" colspan="4">Primary tumor (T)</td> </tr> <tr class="divider_bottom"> <td><strong>T category</strong></td> <td colspan="3"><strong>T criteria</strong></td> </tr> <tr> <td class="indent1">TX</td> <td colspan="3">Primary tumor cannot be assessed</td> </tr> <tr> <td class="indent1">T0</td> <td colspan="3">No evidence of primary tumor</td> </tr> <tr> <td class="indent1">Tis</td> <td colspan="3">Carcinoma <em>in situ</em>, intramucosal carcinoma (involvement of lamina propria with no extension through muscularis mucosae)</td> </tr> <tr> <td class="indent1">T1</td> <td colspan="3">Tumor invades the submucosa (through the muscularis mucosa but not into the muscularis propria)</td> </tr> <tr> <td class="indent1">T2</td> <td colspan="3">Tumor invades the muscularis propria</td> </tr> <tr> <td class="indent1">T3</td> <td colspan="3">Tumor invades through the muscularis propria into pericolorectal tissues</td> </tr> <tr> <td class="indent1">T4</td> <td colspan="3">Tumor invades* the visceral peritoneum or invades or adheres<sup>¶</sup> to adjacent organ or structure</td> </tr> <tr> <td class="indent2">T4a</td> <td colspan="3">Tumor invades* through the visceral peritoneum (including gross perforation of the bowel through tumor and continuous invasion of tumor through areas of inflammation to the surface of the visceral peritoneum)</td> </tr> <tr> <td class="indent2">T4b</td> <td colspan="3">Tumor directly invades* or adheres<sup>¶</sup> to adjacent organs or structures</td> </tr> <tr class="divider_bottom"> <td class="indent1" colspan="4">* Direct invasion in T4 includes invasion of other organs or other segments of the colorectum as a result of direct extension through the serosa, as confirmed on microscopic examination (for example, invasion of the sigmoid colon by a carcinoma of the cecum) or, for cancers in a retroperitoneal or subperitoneal location, direct invasion of other organs or structures by virtue of extension beyond the muscularis propria (ie, respectively, a tumor on the posterior wall of the descending colon invading the left kidney or lateral abdominal wall; or a mid or distal rectal cancer with invasion of prostate, seminal vesicles, cervix, or vagina).<br/> ¶ Tumor that is adherent to other organs or structures, grossly, is classified cT4b. However, if no tumor is present in the adhesion, microscopically, the classification should be pT1-4a depending on the anatomical depth of wall invasion. The V and L classification should be used to identify the presence or absence of vascular or lymphatic invasion whereas the PN prognostic factor should be used for perineural invasion.</td> </tr> <tr class="divider_top"> <td class="subtitle1_left" colspan="4">Regional lymph nodes (N)</td> </tr> <tr class="divider_bottom"> <td><strong>N category</strong></td> <td colspan="3"><strong>N criteria</strong></td> </tr> <tr> <td class="indent1">NX</td> <td colspan="3">Regional lymph nodes cannot be assessed</td> </tr> <tr> <td class="indent1">N0</td> <td colspan="3">No regional lymph node metastasis</td> </tr> <tr> <td class="indent1">N1</td> <td colspan="3">One to three regional lymph nodes are positive (tumor in lymph nodes measuring ≥0.2 mm), or any number of tumor deposits are present and all identifiable lymph nodes are negative</td> </tr> <tr> <td class="indent2">N1a</td> <td colspan="3">One regional lymph node is positive</td> </tr> <tr> <td class="indent2">N1b</td> <td colspan="3">Two or three regional lymph nodes are positive</td> </tr> <tr> <td class="indent2">N1c</td> <td colspan="3">No regional lymph nodes are positive, but there are tumor deposits in the: <ul class="decimal_heading"> <li>Subserosa </li> <li>Mesentery </li> <li>Nonperitonealized pericolic, or perirectal/mesorectal tissues </li> </ul> </td> </tr> <tr> <td class="indent1">N2</td> <td colspan="3">Four or more regional nodes are positive</td> </tr> <tr> <td class="indent2">N2a</td> <td colspan="3">Four to six regional lymph nodes are positive</td> </tr> <tr class="divider_bottom"> <td class="indent2">N2b</td> <td colspan="3">Seven or more regional lymph nodes are positive</td> </tr> <tr class="divider_top"> <td class="subtitle1_left" colspan="4">Distant metastasis (M)</td> </tr> <tr class="divider_bottom"> <td><strong>M category</strong></td> <td colspan="3"><strong>M criteria</strong></td> </tr> <tr> <td class="indent1">M0</td> <td colspan="3">No distant metastasis by imaging, etc; no evidence of tumor in distant sites or organs. (This category is not assigned by pathologists.)</td> </tr> <tr> <td class="indent1">M1</td> <td colspan="3">Metastasis to one or more distant sites or organs or peritoneal metastasis is identified</td> </tr> <tr> <td class="indent2">M1a</td> <td colspan="3">Metastasis to one site or organ is identified without peritoneal metastasis</td> </tr> <tr> <td class="indent2">M1b</td> <td colspan="3">Metastasis to two or more sites or organs is identified without peritoneal metastasis</td> </tr> <tr class="divider_bottom"> <td class="indent2">M1c</td> <td colspan="3">Metastasis to the peritoneal surface is identified alone or with other site or organ metastases</td> </tr> <tr class="divider_top"> <td class="subtitle1_left" colspan="4">Prognostic stage groups</td> </tr> <tr class="divider_bottom"> <td><strong>When T is...</strong></td> <td><strong>And N is...</strong></td> <td><strong>And M is...</strong></td> <td><strong>Then the stage group is...</strong></td> </tr> <tr> <td class="indent1">Tis</td> <td>N0</td> <td>M0</td> <td>0</td> </tr> <tr> <td class="indent1">T1, T2</td> <td>N0</td> <td>M0</td> <td>I</td> </tr> <tr> <td class="indent1">T3</td> <td>N0</td> <td>M0</td> <td>IIA</td> </tr> <tr> <td class="indent1">T4a</td> <td>N0</td> <td>M0</td> <td>IIB</td> </tr> <tr> <td class="indent1">T4b</td> <td>N0</td> <td>M0</td> <td>IIC</td> </tr> <tr> <td class="indent1">T1-T2</td> <td>N1/N1c</td> <td>M0</td> <td>IIIA</td> </tr> <tr> <td class="indent1">T1</td> <td>N2a</td> <td>M0</td> <td>IIIA</td> </tr> <tr> <td class="indent1">T3-T4a</td> <td>N1/N1c</td> <td>M0</td> <td>IIIB</td> </tr> <tr> <td class="indent1">T2-T3</td> <td>N2a</td> <td>M0</td> <td>IIIB</td> </tr> <tr> <td class="indent1">T1-T2</td> <td>N2b</td> <td>M0</td> <td>IIIB</td> </tr> <tr> <td class="indent1">T4a</td> <td>N2a</td> <td>M0</td> <td>IIIC</td> </tr> <tr> <td class="indent1">T3-T4a</td> <td>N2b</td> <td>M0</td> <td>IIIC</td> </tr> <tr> <td class="indent1">T4b</td> <td>N1-N2</td> <td>M0</td> <td>IIIC</td> </tr> <tr> <td class="indent1">Any T</td> <td>Any N</td> <td>M1a</td> <td>IVA</td> </tr> <tr> <td class="indent1">Any T</td> <td>Any N</td> <td>M1b</td> <td>IVB</td> </tr> <tr> <td class="indent1">Any T</td> <td>Any N</td> <td>M1c</td> <td>IVC</td> </tr> </tbody></table></div><div class="graphic_footnotes">TNM: Tumor, Node, Metastasis; AJCC: American Joint Committee on Cancer; UICC: Union for International Cancer Control.</div><div class="graphic_reference">Used with permission of the American College of Surgeons, Chicago, Illinois. The original source for this information is the AJCC Cancer Staging Manual, Eighth Edition (2017) published by Springer International Publishing. Corrected at 4th printing, 2018.</div><div id="graphicVersion">Graphic 111438 Version 11.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
